NCT00596492 - DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions

Mature Cataracts

Interventions

DRUG

DYME

2ml of 0.05 mg/ml BBG 250 in sterile ophthalmic solution

DRUG

DYME

2ml of 0.25 mg/ml BBG 250 in sterile ophthalmic solution

Trial Locations (15)

11514

Island Eye Surgicenter, Carle Place

18704

Eye Care Specialists, Kingston

33176

Center for Excellence in Eye Care, Miami

63131

Ophthalmology Consultants, Ltd., Des Peres

63141

Ballas Surgery Center, St Louis

64133

Silverstein Eye Centers, Kansas City

65804

St. John's Clinic Eye Specialists, Springfield

90301

Peace Laser Eye Center, Inglewood

500034

LV Prasad Eye Institute, Hyderabaad

560020

Narayana Nethralaya, Bangalore

560052

Bhagwan Mahaveer Jain Hospital, Bangalore

560099

Narayana Nethralaya, Bangalore

600006

Sankara Nethralaya, Chennai

07424

Brar-Parekh Eye Associates, Woodland Park

400 007

Bombay City Eye Institute & Research Centre, Mumbai